Skip to main content

. 1954 Feb 13;1(4858):364–365. doi: 10.1136/bmj.1.4858.364

Fatal Case of Marrow Aplasia after Treatment with Carbimazole

J S Richardson, I Sarkany, C D Campbell

PMCID: PMC2084611 PMID: 13115722

364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BERNFELD P., STEFANINI M. Characteristic electrophoretic patterns in hemophilia and idiopathic thrombocytopenia. Proc Soc Exp Biol Med. 1951 Jul;77(3):551–553. doi: 10.3181/00379727-77-18846. [DOI] [PubMed] [Google Scholar]
CROKE A. R., BERRY J. W. Agranulocytosis occurring during methimazole tapazole therapy; report of a case. J Am Med Assoc. 1951 Jan 5;145(1):45–47. doi: 10.1001/jama.1952.62930010002010a. [DOI] [PubMed] [Google Scholar]
DAVIDSON L. A. Clinical trial of methimazole in treatment of thyrotoxicosis. Br Med J. 1953 Dec 12;2(4849):1300–1303. doi: 10.1136/bmj.2.4849.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
DONIACH D. Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases. Lancet. 1953 May 2;1(6766):873–879. doi: 10.1016/s0140-6736(53)92004-2. [DOI] [PubMed] [Google Scholar]
LAWSON A., BARRY G. Treatment of thyrotoxicosis with 2-carbethoxythio-1-methylglyoxaline (C.G.1). Lancet. 1951 Oct 6;2(6684):621–621. doi: 10.1016/s0140-6736(51)92893-0. [DOI] [PubMed] [Google Scholar]
POATE H. Thyrotoxicosis treated with 2-carbethoxythio-1-methylglyoxaline (neo mercazole). Lancet. 1953 May 2;1(6766):879–881. doi: 10.1016/s0140-6736(53)92005-4. [DOI] [PubMed] [Google Scholar]
ROSENBAUM H. Agranulocytosis and toxic hepatitis from methimazole. J Am Med Assoc. 1953 May 2;152(1):27–27. doi: 10.1001/jama.1953.63690010003007b. [DOI] [PubMed] [Google Scholar]
SPECHT N. W., BOEHME E. J. Death due to agranulocytosis induced by methimazole therapy. J Am Med Assoc. 1952 Jul 12;149(11):1010–1011. doi: 10.1001/jama.1952.72930280001009. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES